| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 09/18/2008 | US20080226705 Gel delivery system for oral administration of medicaments |
| 09/18/2008 | US20080226704 Method of Producing Coated Fine Particles |
| 09/18/2008 | US20080226703 Human Growth Hormone Patch Formulations |
| 09/18/2008 | US20080226701 Medicated patches |
| 09/18/2008 | US20080226700 Containing allantoin and plant extracts; skin disorders; antiulcer agents |
| 09/18/2008 | US20080226699 Method and System for Rapid Transdermal Administration |
| 09/18/2008 | US20080226698 Amorphous drug transdermal systems, manufacturing methods, and stabilization |
| 09/18/2008 | US20080226697 Mixture of transdermal absorption promoter and drug; stabilized with polyvinylpyrrolidone; prevent vaporization or degradation |
| 09/18/2008 | US20080226695 Water degradation; controlled drying; self-supporting edible film; uniform distribution; mixing water soluble polymer with water and active material; deaeration |
| 09/18/2008 | US20080226689 Apparatus for uniform delivery of drugs to biological systems |
| 09/18/2008 | US20080226688 Glass particles in aqueous carrier mixture containing glycerol and polyoxyethylene glycol |
| 09/18/2008 | US20080226687 Drug delivery and method having coated microprojections incorporating vasoconstrictors |
| 09/18/2008 | US20080226686 Generation of nitric oxide in situ at substrate/blood interfaces and reproducible nitric oxide sensor for detecting nitrosothiols |
| 09/18/2008 | US20080226684 Method and process for the production of multi-coated recognitive and releasing systems |
| 09/18/2008 | US20080226674 Anticancer drugs encapsulated in and mixed with envelop protein virus vector; intensify immunology response in animals |
| 09/18/2008 | US20080226625 Stable non- aqueous single phase viscous vehicles and formulations utlizing such vehicles |
| 09/18/2008 | US20080226623 Stabilized protein crystals, formulations comprising them and methods of making them |
| 09/18/2008 | US20080226617 Recombinant human arginase functioning as arginine depleting agent in treatment of cell proliferative disorders |
| 09/18/2008 | US20080226584 Film forming cationic polymer and polymer blends; cosmetics |
| 09/18/2008 | US20080226564 Bioactive material in perforated microstructure; propellant suspension; mixture of bronchodilator and antiinflammatory agent |
| 09/18/2008 | US20080226556 Using macrophages;milk fat globulins; epidermal growth factor mutants |
| 09/18/2008 | DE202006020331U1 Neue, pharmazeutische modifizierte Freisetzungs-Dosisform Cyclooxygenase-Enzym-Inhibitor New, modified release pharmaceutical dosage form cyclooxygenase enzyme inhibitor |
| 09/18/2008 | DE102007012105A1 Pellets enthaltend pharmazeutische Substanz, Verfahren zu deren Herstellung und deren Verwendung Pellets containing pharmaceutical substance, process for their preparation and their use |
| 09/18/2008 | DE102007011556A1 Auflösbare Kapsel für die Durchgangsprüfung des Darm-Trakts Dissolvable capsule for the continuity test of the intestinal tract |
| 09/18/2008 | DE102007009243A1 Pellets mit einer Wirkstoff-Matrix und einem Polymerüberzug, sowie ein Verfahren zur Herstellung der Pellets Pellets with an active matrix and a polymer coating, and a process for the preparation of the pellets |
| 09/18/2008 | DE102007009242A1 Pellets mit magensaftresistenter Wirkstoff-Matix Pellets with enteric drug Matix |
| 09/18/2008 | CA2718571A1 Oral zinc medicants useful for safely lowering free copper absorption and free copper levels |
| 09/18/2008 | CA2681159A1 Immunoactive compositions for improved oral delivery of vaccines and therapeutic agents |
| 09/18/2008 | CA2681158A1 Methods and compositions for the sustained release of chromium |
| 09/18/2008 | CA2680608A1 Pharmaceutical composition |
| 09/18/2008 | CA2680481A1 Intravesical apaziquone administration following transurethral resection for treating cancer |
| 09/18/2008 | CA2680405A1 Polyaphron topical composition with vitamin d and corticosteroid |
| 09/18/2008 | CA2680321A1 Bio-artificial pancreas and a procedure for preparation of same |
| 09/18/2008 | CA2680249A1 Imatinib mesylate |
| 09/18/2008 | CA2680230A1 A method of promoting tissue repair |
| 09/18/2008 | CA2680193A1 Lyophilized preparation comprising influenza vaccine, and method for preparation thereof |
| 09/18/2008 | CA2680074A1 Topical pharmaceutical formulation |
| 09/18/2008 | CA2679643A1 Procaspase 8-mediated disease targeting |
| 09/18/2008 | CA2679210A1 Time- specific delayed/pulsatile release dosage forms |
| 09/18/2008 | CA2678876A1 Orally administrable films |
| 09/18/2008 | CA2677897A1 Stabilized micronised particles |
| 09/18/2008 | CA2676981A1 Powders for reconstitution |
| 09/17/2008 | EP1970366A1 Isohumulone compound clathrate and composition containing the same |
| 09/17/2008 | EP1970078A1 Composition inhibiting the expression of target gene in eyeball and remedy for disease in eyeball |
| 09/17/2008 | EP1970076A1 Pharmaceutical composition for application to nail |
| 09/17/2008 | EP1970071A1 Use of a topical composition containing epidermal growth factor (egf) for diabetic foot amputation prevention |
| 09/17/2008 | EP1970067A1 Pharmaceutical compound for treating acidaemia |
| 09/17/2008 | EP1970066A1 Pharmaceutical compound for treating acidaemia |
| 09/17/2008 | EP1970058A1 Epidermal growth factor receptor antagonists for treating hypersecretion of mucus in the lungs |
| 09/17/2008 | EP1970057A1 Process for the preparation of stable pharmaceutical compositions of 2-(R) - (1-(R)-(3, 5- bis (trifluoromethyl) phenyl) ethoxy)-3-(S)-(4-fluoro) phenyl-4-(3-(5-oxo-1H, 4H-1, 2, 4-triazolo) methylmorpholine (aprepitant) |
| 09/17/2008 | EP1970056A1 Time-specific delayed/pulsatile release dosage forms |
| 09/17/2008 | EP1970055A2 Multi-layered tablet with triple release combination |
| 09/17/2008 | EP1970054A2 Clopidogrel tablets |
| 09/17/2008 | EP1970053A1 Pharmaceutical composition |
| 09/17/2008 | EP1970052A2 Basic drug compositions with enhanced bioavailability |
| 09/17/2008 | EP1970051A1 Use of an aqueous micro-emulsion for the preparation of a formulation for the treatment of adipose diseases |
| 09/17/2008 | EP1970050A1 Intravenous emulsion of butylbenzene phthalein and its application |
| 09/17/2008 | EP1970049A1 Polyaphron topical composition with vitamin D and corticosteroid |
| 09/17/2008 | EP1970048A1 Polyaphron topical composition with vitamin D |
| 09/17/2008 | EP1970047A1 Polyaphron topical composition with a corticosteroid |
| 09/17/2008 | EP1970040A1 Method of producing drug-containing wax matrix particles, extruder to be used in the method and sustained-release preparation containing cilostazol |
| 09/17/2008 | EP1969134A1 Modified release amoxicillin products |
| 09/17/2008 | EP1968981A2 A method of treating tumors with azaxanthones |
| 09/17/2008 | EP1968926A1 Spherical menthol particles |
| 09/17/2008 | EP1968711A2 Dermatological viscoelastic gel |
| 09/17/2008 | EP1968627A2 Compositions for disrupting and inhibiting reconstitution of wound biofilm |
| 09/17/2008 | EP1968613A1 Chitosan-based particles |
| 09/17/2008 | EP1968611A2 Transdermal delivery means of a diuretic agent and/or cardiac glycoside agent |
| 09/17/2008 | EP1968609A2 Pharmaceutical compositions and methods of use of highly lipophilic sulfhydryl compounds |
| 09/17/2008 | EP1968605A1 Emulsions comprising non-esterified phytosterols in the aqueous phase |
| 09/17/2008 | EP1968592A2 Formulations comprising jorumycin-, renieramycin-, safracin- or saframycin-related compounds for treating proliferative diseases |
| 09/17/2008 | EP1968586A2 Pharmaceutical compositions and methods for improved bacterial eradication |
| 09/17/2008 | EP1968567A1 Omega 3 fatty acid formulations |
| 09/17/2008 | EP1968562A2 Multilayer tablet |
| 09/17/2008 | EP1968558A2 Ph modulated films for delivery of actives |
| 09/17/2008 | EP1968557A1 Encapsulated chromonic particles |
| 09/17/2008 | EP1968556A1 Composition, and use thereof, in respect if cancer, prophylactic treatment and infection in the urinary tract, involving nitric oxide |
| 09/17/2008 | EP1968555A2 Masking the taste of powders |
| 09/17/2008 | EP1968554A2 Bioadhesive drug formulations for oral transmucosal delivery |
| 09/17/2008 | EP1968553A2 Process for making pharmaceutical compositions with a transient plasticizer |
| 09/17/2008 | EP1968552A1 Pack |
| 09/17/2008 | EP1968551A2 Stable pharmaceutical compositions of 5,10 methylenetetrahydrofolate |
| 09/17/2008 | EP1968550A2 Nanoclusters for delivery of therapeutics |
| 09/17/2008 | EP1968549A1 Sustained release formulation comprising octreotide and two or more polylactide-co-glycolide polymers |
| 09/17/2008 | EP1968548A2 Mometasone compositions and methods of making and using the same |
| 09/17/2008 | EP1968547A1 Process for the preparation of micronised sterile steroids |
| 09/17/2008 | EP1968546A2 Stables s-nitrosothiol formulations |
| 09/17/2008 | EP1968545A2 Medicament for topical use |
| 09/17/2008 | EP1968544A2 Drug delivery system for bioadhesion to a vulvovaginal surface |
| 09/17/2008 | EP1968543A2 Composition and method of use thereof |
| 09/17/2008 | EP1968542A1 Solid dispersion comprising an active ingredient having a low melting point and tablet for oral administration comprising same |
| 09/17/2008 | EP1968540A2 Topical drug delivery by iontophoresis |
| 09/17/2008 | EP1968539A2 Abuse resistant transmucosal drug delivery device |
| 09/17/2008 | EP1968538A1 Pharmaceutical compositions comprising cyclosporin |
| 09/17/2008 | EP1968537A1 Pharmaceutical compositions stabilized in glassy particles |
| 09/17/2008 | EP1968523A1 A plant and a process for production of tablets |
| 09/17/2008 | EP1796668B1 Aqueous pharmaceutical preparation comprising roflumilast |
| 09/17/2008 | EP1753293A4 Anti-microbial activity of biologically stabilized silver nano particles |
| 09/17/2008 | EP1677687A4 Delivery of polymer conjugates of therapeutic peptides and proteins via coated microporjections |
| 09/17/2008 | EP1673070A4 Preparation method for sustained release microspheres using a dual-feed nozzle |